Agenda

Updates in Stroke Prevention: Novel Diagnostics, Devices, Drugs

*The program is preliminary and could be subject to changes

  7:00 – 8:00 am

FULL BREAKFAST PROVIDED

North Ballroom

  8:00 – 8:15 am

MISSION, GOALS AND OBJECTIVES OF RAISE II

South Ballroom

RAISE Chairpersons: M. Edip Gurol (Neurology, MGH/HMS)
Marc Fisher (Neurology, BIDMC/HMS)

  8:15 – 10:05 am

SESSION 1: NOVEL DIAGNOSTICS AND THE USE OF AI IN STROKE PREVENTION 

South Ballroom

Co-Chairs: Dawn Kleindorfer (Neurology, U. Michigan), Bradford Worrall (Neurology, Univ. Virginia)

8:15–8:27: Using 12-leads EKG to Predict Afib and Other Conditions
Paul Friedman (Cardiology, Mayo Clinic, Rochester, MN)

8:27 – 8:39 Wearables for Stroke Prevention Research
Michael Gibson (Cardiology, BIDMC)

8:39 – 8:51 Long-term monitoring for AFib Detection
Tina Baykaner (Cardiology, Stanford)

8:51 – 9: 03 AI and Big Data in Stroke Prevention Research
Nassir Marrouche (Cardiac EP, Tulane Univ.)

09:03 – 09:15 Advances in Cardiac Imaging
TBA

09:15 – 10:05 Discussion
Jose Merino (Neurology, Georgetown), TBA

  10:05 – 10:25 am

BREAK

North Ballroom

  10:25 am– 12:15 pm

SESSION 2: PREVENTION OF ISCHEMIC AND HEMORRHAGIC STROKES IN ATRIAL FIBRILLATION

South Ballroom

Co-Chairs: Cheryl Bushnell (Neurology, Wake Forest), and Clinton Wright (NINDS)

10:25 – 10:37 Factor XIa inhibitors in AFib
Jonathan Piccini
(Cardiac EP, Duke)

10:37 – 10: 49 Updates in Left Atrial Appendage Closure for Stroke Prevention in AFib
Mohit Turagam
(Cardiac EP, NYC, NY)

10:49 – 11:01 Atrial Fibrillation Ablation and Stroke Risk
Vivek Reddy (Cardiac EP, NYC, NY)

11:01 – 11:13 Atrial Fibrillation and Cognitive Impairment 
Rebecca Gottesman (NINDS)

11:13 – 11:25 Incorporating Advances in AFib Treatment into Clinical Practice: Challenges and Opportunities
Edip Gurol (MGH/HMS, Boston, MA)

11:25 – 12:15 Discussion
Magdy Selim (Neurology, Harvard Medical School), Clay Johnston, TBA

 

  12:15 – 1:15 pm

LUNCH

North Ballroom

  1:15 – 3:05 pm

SESSION 3: NEW DRUGS FOR STROKE PREVENTION

South Ballroom

Chairs:  Argye Hillis (Neurology, JHU), Valentin Fuster (Cardiology, Mount Sinai)

1:15 – 1:27 P2Y12 inhibitors: When to Use? What Other Data Do We Need?
Greg Albers (Neurology, Stanford)

1:27 – 1:39 GLP-1 Receptor Agonists and SGLT-2 Inhibitors for Stroke Prevention
Eda Cengiz (Endocrinology, UCSF)

1:39 – 1: 51 All ESUS / “Atrial Cardiopathy” Studies Failed: Now What?

Mitch Elkind (AHA)

1:51 – 2: 03 Updates on Management of Hyperlipidemia for Stroke Prevention
Seemant Chaturvedi (Neurology, University of Maryland)

2:03 – 2:15 How to design a trial to achieve FDA approval for a new indication
Andrew Farb
(FDA)

2:15 – 3:05 Discussion
Hooman Kamel (Neurology, Cornell), TBA

  3:05 – 3:20 pm

BREAK

North Ballroom

  3:20 – 5:10 pm

SESSION 4: NOVEL DEVICES FOR STROKE PREVENTION

South Ballroom

Co-Chairs:  Louise McCullough (UT Houston Neurology), , Scott Janis (NINDS)

3:20 – 3: 32 New/Potential Studies in PFO Closure
Jeff Saver (Neurology, UCLA)

3:32 – 3:44 Renal Denervation for Hypertension Control
Naomi Fisher (Endocrinology, BWH, Boston, MA)

3:44 – 3:56 Prophylactic Ablation and LAA Obliteration During Major Cardiac Surgery
DJ Lakkireddy (Cardiac EP, Kansas City)

3:56 – 4:08 Stroke During Major Endovascular Procedures & Emerging Protective Devices
TBA

4:08 – 4:35 Special LectureFDA-approval process for drugs and devices: progress and challenges
Robert M. Califf
(United States Commissioner of Food and Drugs)

4:35 – 5:10 Discussion
Nicole Sur (U. Miami Neurology), Joseph Broderick (Univ. Cincinnati), TBA

  6:30 – 7:30 pm

COCKTAIL RECEPTION

Galaxy Ballroom

  7:30 – 9:30 pm

DINNER FOLLOWED BY А SPECIAL PRESENTATIONS

Galaxy Ballroom

TBA

  7:00 – 8:00 am

FULL BREAKFAST PROVIDED

North Ballroom

  8:00 – 10:30 am

WORKSHOPS TO DEVELOP CONSENSUS RECOMMENDATIONS

Participants are divided into three groups – each to develop recommendations.

Workshop 1:  Novel Approaches to Stroke Prevention in Atrial Fibrillation
Moderators: Alvin Das (Neurology, BI/HMS, Boston), Shadi Yaghi (Neurology, Brown, RI), David Holmes (Cardiology, Mayo Rochester MN)

Workshop 2: New Drugs for Non-AFib Stroke Prevention
Moderators:
Baris Alten (Neurology, MGH/HMS, Boston), Luciano Sposato (Canada), TBA

Workshop 3: New Devices for Non-AFib Stroke Prevention
Moderators: Adam Russak (Cardiology, Mount Sinai), Eric Smith (Univ. Calgary), Ajay Kirtane (Cardiology, Columbia)

  10:30 – 10:45 am

BREAK

North Ballroom

  10:45 am – 12:00 pm

WORKSHOP CHAIRS PRESENT RECOMMENDATIONS TO FULL ASSEMBLY

Drafting of consensus statement is initiated

Drafting of consensus statement is initiated – Chaired by M. Edip Gurol (MGH/HMS)

 

  12:00 – 12:15 pm

CLOSING COMMENTS AND ADJOURNMENT